Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
it will webcast its corporate presentation at the Canaccord Adams Global
Growth Conference on Tuesday, August 11, 2009 at 10:30 a.m. EDT.
The presentation will be webcast live and may be accessed from ‘Events &
Presentations’ on the home page of Vertex’s website at www.vrtx.com.
A replay of the webcast will also be available on the Company’s website
for two weeks following the presentation. To ensure a timely connection,
it is recommended that users register at least 15 minutes prior to the
scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small
molecule drugs for serious diseases. The Company’s strategy is to
commercialize its products both independently and in collaboration with
major pharmaceutical companies. Vertex’s product pipeline is focused on
viral diseases, cystic fibrosis, inflammation, autoimmune diseases,
cancer, and pain. Vertex co-discovered the HIV protease inhibitor,
Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex’s press releases are available at www.vrtx.com.
(VRTX-WEB)
Vertex Pharmaceuticals Incorporated
Lora Pike, 617-444-6755
Associate
Director, Investor Relations
